chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a registered nurse referring to 5 unspecified patients of unknown age and gender. The patients' pertinent medical history, concurrent conditions and drug reactions/allergies were not reported. On 22-OCT-2015, the patients were vaccinated with doses of MMR II, lot # L015281 with expiration date 30-APR-2017, (dose and route of administration were not provided); which were exposed to 10.9 C for 2 hours and 48 minutes. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Upon initiation of shot, patient had immediate discomfort/pain in the left arm. Felt like a regular shot, then in doing regular activity, by day 3 and on that the arm is sore and she does not want to perform activities. Inconsistent times of discomfort with varying arm movements. There is a small green discolored area on the left deltoid, appears to be healing bruise.
Fever lasting 48hrs; tiredness; full body aches (most intense at injection site); full body aches (most intense at injection site); headaches; chills; sweating; Wrong vaccine administered; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 29Sep2022 at 11:15 as dose 1, single (Lot number: GJ6742) at the age of 33 years intramuscular, in left arm for covid-19 immunisation. The patient didn't receive BNT162b2 (BNT162B2). The patient's relevant medical history included: "Known allergies: Sulpha Antibiotics" (unspecified if ongoing). Concomitant medication(s) included: TRUMENBA taken for immunisation, on 09Sep2022 as dose number unknown, single; INFLUENZA taken for immunisation, on 09Sep2022 as dose number unknown,  single.  The following information was reported: WRONG PRODUCT ADMINISTERED (non-serious) with onset 29Sep2021, outcome "unknown", described as "Wrong vaccine administered"; PYREXIA (non-serious) with onset 29Sep2022 at 14:45, outcome "recovering", described as "Fever lasting 48hrs"; CHILLS (non-serious) with onset 29Sep2022 at 14:45, outcome "recovering"; PAIN (non-serious), VACCINATION SITE PAIN (non-serious) all with onset 29Sep2022 at 14:45, outcome "recovering" and all described as "full body aches (most intense at injection site)"; HEADACHE (non-serious) with onset 29Sep2022 at 14:45, outcome "recovering", described as "headaches"; HYPERHIDROSIS (non-serious) with onset 29Sep2022 at 14:45, outcome "recovering", described as "sweating"; FATIGUE (non-serious) with onset 29Sep2022 at 14:45, outcome "recovering", described as "tiredness". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, fatigue, pain, vaccination site pain, headache, chills, hyperhidrosis.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Onset papular, urticarial rash approx. 24 hrs after administration of Td booster began on arm booster given in spread to other arm and legs over two day period when seen three days after booster. Urticaria treated wtih Benadryl and steroid cream.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021 at 3:30 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 20-Mar-2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 30.14.  Concomitant products were not provided. On 20-Mar-2021, Excursion time was 9 AM, 10 AM temperature was 34, 37 total doses given for the day was 184, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 09-Mar-2021, vial was moved to clinic on 20-Mar-2021. 19 vials were sent to clinic. Vaccine BUD date was 08-Apr-2021. On 20-Mar-2021, vials were stored in cooler 1, at following time and temperature respectively, 9 AM: 34, 10 AM: 30, 11 AM: 41, 12 AM: 45, 1PM: 44, 2 PM: 44, 3 PM: 44, 4 PM: 44 and 5 PM: 43.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.   This case was linked to MOD-2022-566976 (Patient Link).
Soreness and pain of the arm; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 32 year-old male patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "stomach" (unspecified if ongoing), notes: Pantoprazole for stomach. Concomitant medication(s) included: ABILIFY; ZOLOFT; KLONOPIN; FENOFIBRATE; CLARITIN [CLARITHROMYCIN]; PANTOPRAZOLE taken for abdominal discomfort. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Soreness and pain of the arm".  Additional Information: The medications he is asking if it's ok to take with the Pfizer Covid19 Booster shot are Abilify, Zoloft, Klonopin, Fenofibrate, prescription Claritin, and Pantoprazole. He stated he received the first and second Covid19 shot and is getting booster. He was on the products Abilify, Zoloft, Klonopin, Fenofibrate, prescription Claritin, and Pantoprazole when he received the first and second dose. After first dose of Pfizer Covid19 shot, the next day the only problem was in the arm where he got it. He couldn't tell it was bothering him, only when he moved it. The second dose was given in Jul2021. He started having symptoms after, but he can't remember. They were one after another.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
On the 4th day after vaccine, I had dizziness, fever, aching all over especially in the legs.  Fever blisters, joints swelling, nausea and diarrhea, sore throat, cough.
redness, swelling & hive around inject site (lt deltoid); rash w/itching; occurred w/in 24 hrs following vax;
Entire left side of body muscle aches and joint aches. Started about 2 hours after getting injection and worse the next day
The patient reported redness and pain at the injection site in an area 4" in diameter. The patient complained of pain from the elbow to the shoulder. Symptoms subsided in 5 days.
Nausea, dizziness, headache, blurry eyes, trouble walking, mouth sores.
10AUG93 pt had fluctuating inc temp since vax given; highest t102; 11AUG(3 MD who dx viral infection; 12AUG93 t105 w/forehead strip thermometer; 13AUG93 2nd visit to MD elevated temp cont; 14AUG93 pt fine, temp nl;
Pt passed out while sitting on a chair after getting first Pfizer COVID vaccine for a short time and woke up. She said she felt hot and dizzy before passing out. Due to the event, pt got a minor skin injury on her chin.
Info has been received from a PA concerning a 12 month old female who on 3/16/05 was vaccinated with a dose of varicella virus vaccine live. On 3/28/05, the pt experienced breakthrough varicella of not more than 50 lesions. The pt is recovering. No treatment is necessary. Unspecified medical attention was sought. No product quality complaint was involved. Additional info has been requested.
got the flu; positive for Influenza A; Initial information received on 18-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-healthcare professional.  This case involves an unknown age and unknown gender patient who got the flu and positive for influenza A after receiving vaccine Influenza Vaccine.   The patient's past medical treatment(s), vaccination(s) and family history were not provided. It is unknown if the patient had any medical history, concomitant disease, or risk factor.  On an unknown date, the patient received unknown dose of suspect Influenza Vaccine produced by unknown manufacturer (lot number, strength, route, formulation, batch number, expiry date and administration site unknown) for prophylactic vaccination.  On an unknown date the patient developed a non-serious event "got the flu (influenza)" and "positive for influenza a (influenza a virus test positive)" (unknown latency) following the administration of Influenza Vaccine. it was reported that the patient have been dealing with flu for over a week.   Relevant laboratory test results included: Influenza - On an unknown date: Positive.  Action taken: not applicable.  The patient was treated with PREDNISONE (PREDNISONE) for Influenza A virus test positive just to get a little relief.  Outcome: Unknown for both the events.
Patient collapsed a few minutes after receiving the vaccine and injured his chin.  Patient was up walking around until time of collapse, and remained laying down until paramedics came.  Patient was transported to the hospital via ambulance.
I am currently experiencing fatigue, muscle/body aches, headache, and confusion. Sometimes I feel disoriented.
Flushing, shortness of breath, fast heart rate, sweating, nausea? 10 minutes after-30 minutes after, took Benadryl and tylenol Fatigue, brain fog, body aches, shoulder and elbow pain, sensitive to touch at injection site, red raised site about a size of quarter- 30 min after-36 hrs after, no treatment Intermittent fever in first 36 hrs
Patient began to complain of bilateral tinnitis within 15 minutes of receiving the vaccine. And by 40 minutes had a headache that began with posterior neck pain and then radiated up into the back of his head
4 hours after injection diarrhea began with chills throughout the night.  On 3/31/21 rash started on right waistline area with swelling on right groin area. On 4/4/21 physician/family member diagnosed shingles.
tingling sensation in my lower leg - in the shin area about 5/6 inches up from the where the leg forms into the foot. It is predominantly my left leg but impacts both legs.  Severe headaches, some dizziness not able to focus on a image.  general brain fog.
This spontaneous report was received from a medical assistant referring to an unspecified number of patients of unspecified demographics. Information regarding the patients' pertinent medical history, drug reactions or allergies and concomitant therapies was not provided. On unknown dates, the unspecified number of improperly stored doses of LIQUID PEDVAXHIB lot # N000235 with an expiration date of 26-OCT-2019, or lot# N000237 with an expiration date of 25-OCT-2019 (dose, route of administration and anatomical location were not reported) were inadvertently administered to the patients. No adverse effects were reported. The vaccines were exposed to temperature of 47 degrees Fahrenheit for 30 minutes before administration to the patients. There was a previous temperature excursion reported, with a temperature of 56 degrees Fahrenheit for 5 hours. The digital data logger was involved. The product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information is not expected, as there was no consent for further contact.; Sender's Comments: US-009507513-1706USA009734: US-009507513-1706USA004159:
Caller is reporting that PROQUAD that underwent a temperature excursion was administered; This spontaneous report was received from a nurse regarding a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, drug reactions and allergies were not provided.   On 17-FEB-2021, the patient was vaccinated with an improperly stored dose (product storage error) of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) valid lot number T027115, expiration date 07-FEB-2022 (dose, vaccination scheme, and route of administration were not reported). Administered dose of vaccine experienced the temperature excursion of -10 Celsius (°C ) to 8 °C  degrees for 22 hours. Data logger was involved. There was no previous excursions reported.
Large red rash on arm over 1 inch in diameter, warmness and pain -- manifested 3 days after administering the vaccine and still present to this day.
knot in my arm; Suffered over 36 hours of low grade fever; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of pyrexia (on 2009 received and also had knot in arm.).   On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced fever (Verbatim: Suffered over 36 hours of low grade fever) and local swelling (Verbatim: knot in my arm).  The outcome of the fever was resolved (duration 36 hrs) and the outcome of the local swelling was resolved.   It was unknown if the reporter considered the fever and local swelling to be related to RSV vaccine.     It was unknown if the company considered the fever and local swelling to be related to RSV vaccine.   Additional Information: GSK Receipt date: 29-SEP-2023 This case was reported by patient via interactive digital media. The patient got the RSV vaccine, suffered over 36 hours of low grade fever and a knot in his/her arm and he/she had to use a shoulder massager to break it up and get my shoulder feeling right again.  The patient states that he/she normally do vaccines well but this one and the Shingles shot back in 2009 gave his/her the same reaction and he/she didn't like it.  Follow up was not possible, as no contact details were available.
FLUMIST given on 11/2/11 - on 11/11/11 - 9 days following vaccine - patient had paralysis on left side of face was taken to ER after recommendation per phone of family Dr. Was diagnosed in ER with Bells Palsy by Dr. - F/U with family dr..
Reddened, cellulitis area received after getting PREVNAR 13 vaccine given on 11-10-15. Placed on 7 day ciprofloxacin therapy.
A report has been received from a Health Professional concerning a female patient, who had been receiving FLUMIST quadrivalent (intranasal), 0.2 milliliters, once/single administration. FLUMIST quadrivalent started on an unknown date. It was reported temperature excursion of FLUMIST that had been given to 14 patients. The patient number three received the FLUMIST, 0.2ml dose, one time intranasally, date of vaccination not provided. It was unknown if the dose of 0.1ml was given in each nostril. The office refrigerator had a temperature excursion of 1.5 degrees C for a total of 17.5 hours. The temperature would be at recommended temperature range and then dip to 1.5 degrees C, then go back to original range. FLUMIST quadrivalent was continued. The outcome of the event of patient number three given FLUMIST vaccine that underwent a temperature excursion, and it is unknown if the dose of 0.1ml was given in each nostril was unknown. The report was considered to be non-serious.
Baby took ROTATEQ fine. Then cried and held his breath during 2nd injection(PREVNAR). It lasted a few seconds. He received PENTACEL first and did fine. He checked out and parents returned secondary baby crying, getting a rash, and having difficulty breathing. Baby was extremely fussy on return to room. Bandaids removed from legs which were a red and blotchy. Pt had oral secretions and would not take TYLENOL or bottle. He had petechiae developing on face. He was worse with laying down. Oxygen 98% and HR 190s, baby stayed very fussy. Pt watched in office x 30 min and would not calm. Ambulance was called to transport to Hospital for reaction from vaccines. Discussed with ED. Recommend monitoring for allergic reaction, checking chest xray to R/O aspiration and CBC secondary to petechiae. Pt returned to office at 520 ambulance called at 545.
This spontaneous report as received from a pharmacist refers to a male patient of unknown age with no drug allergies/reactions. On 08-NOV-2013 the patient was vaccinated with a dose of  ZOSTAVAX (lot # J006831, expiration date 14-SEP-2013, 0.65 ml, subcutaneously. On an unknown date in November 2013 the injection site became painful to touch and painful with flexing of the arm after the patient was administered ZOSTAVAX. The patient called the pharmacist on 11-NOV-2013 and stated that these adverse symptoms had not improved. Additional information has been requested.
Headache; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and VOMITING (Vomiting) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     Concurrent medical conditions included Sensitivity to weather change (medical history reported as weather related issues).    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced HEADACHE (Headache) and VOMITING (Vomiting). At the time of the report, HEADACHE (Headache) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
She didn't felt like herself, achy and high grade fever.  The following day, she came down with chickenpox rash mainly on her face and chest, and some little blisters on her arms and a few on her back.
02/18/22 presents to ED for "fatigue, nausea, diarrhea, chills and a non productive cough". PMHx of "HFrEF, prostate cancer, CAD, valvular heard disease s/p valve replacement, plaque psoriasis"
Information has been received from the registered nurse concerning to an approximately 61 year old patient of unknown gender. Patient's concurrent conditions and relevant medical history was not reported. On 12-DEC-2014, the patient was vaccinated with improperly stored dose of PNEUMOVAX 23 (lot number: K005402 with unknown expiration date) (dose, route and frequency unspecified). Concomitant medications were not reported. No adverse event was reported. The outcome of the event was unknown. The causality of the events with PNEUMOVAX 23 was not reported. This is one of the several reports from the same reporter. Additional information has been requested.
Fever to 103 within 24hrs of immunizations. Redness and swelling at B thigh injection sites. Improved within 48 hr from time of injections.
mom noticed boil-like area @ inject site on 7OCT93 & took pt to MD; prescribed oral ATB w/ no dec in size in 3 days; I&D abscess done by MD;
feeling unwell/ generally feeling unwell; looked tired; glassy eyed; Looks tired and sick; like he has a cold; Dose 1, Dose 2, Dose 3 :Moderna / Dose 4: Pfizer; Chills; feeling shaky; Looks tired and sick; like he has a cold; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 77-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Oct2022 at 04:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 77 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Moderna covid-19 vaccine (DOSE 1, SINGLE), for COVID-19 immunisation; Moderna covid-19 vaccine (DOSE 2, SINGLE), for COVID-19 immunisation; Moderna covid-19 vaccine (DOSE 3 (BOOSTER), SINGLE), for COVID-19 immunisation. The following information was reported: CHILLS (non-serious) with onset 11Oct2022, outcome "unknown"; INTERCHANGE OF VACCINE PRODUCTS (non-serious) with onset 11Oct2022, outcome "unknown", described as "Dose 1, Dose 2, Dose 3 :Moderna / Dose 4: Pfizer"; NASOPHARYNGITIS (non-serious), ILLNESS (non-serious) all with onset 11Oct2022, outcome "unknown" and all described as "Looks tired and sick; like he has a cold"; NERVOUSNESS (non-serious) with onset 11Oct2022, outcome "unknown", described as "feeling shaky"; EYE DISORDER (non-serious) with onset 11Oct2022, outcome "unknown", described as "glassy eyed"; FATIGUE (non-serious) with onset 11Oct2022, outcome "unknown", described as "looked tired"; MALAISE (non-serious) with onset 11Oct2022 at 04:00, outcome "unknown", described as "feeling unwell/ generally feeling unwell". Therapeutic measures were taken as a result of chills, nervousness, nasopharyngitis, malaise, fatigue, eye disorder, illness.  Additional information: The reporter stated that the patient received the new booster dose "this morning" and "around 4pm" he started feeling unwell. The reporter added that "he" was having "chills, looked tired, feeling shaky, and generally feeling unwell" and when she checked up on him, he was "glassy eyed". She added that her significant other received 3 doses of Moderna vaccines before receiving this new booster dose. She also mentioned that she gave him 2 Tylenol. She wanted to know if the symptoms will persist and is there anything he could take to combat these symptoms.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Covid arm-4 red splotches on my right arm 12 days after  vaccination.
Maybe 2 or 2 1/2 weeks after getting the vaccine, the injection site became itchy, red, a little bit raised, and hot to the touch I would say the area of redness was probably about 2 inches in diameter. I had the usual arm soreness/tenderness right after the injection, which went away within a few days, so this was a later reaction that started with itching. Even 4 1/2 weeks later, it still itches from time to time, though the redness, swelling and heat are gone.
Pt came in 4/23/21 to receive second dose of Covid-19 vaccine. It was noted the patient had received the Moderna vaccine for his first dose on 3/26/21 and the patient is only 16 yoa. The pt is the son of one of the FireFighters, who works for the site often. The night the pt received the dose, it was an extra dose and was administered by the pts father. Upon realization of mistake on 4/23/21, the medical OIC contacted for advice. It was instructed to give the pt the second dose Moderna and submit a VAERS report. Pt and mother, who was in attendance are aware and unconcerned at this time.
Erythrodema, mild swelling, dorsa of hands and feet; fine erhthematous maculo papular eruption, chest, abdomen and thighs.  A follow up report received 9/18/2002 adds: Dx viral exanthea vs possible reaction. No fever. Rx Aveno both, Benadryl.